Why the study?
Does immunostaining with QBEnd/10 improve the diagnosis of Kaposi's sarcoma compared to UEA-1 and FVIIIRAg?
Population
60 skin tumour samples
Comparison
Immunostaining with QBEnd/10 on routine… vs Immunostaining with Ulex europaeus agglutinin 1…
Design
Cohort
Authors
Loading...
QBEnd/10 may aid Kaposi's sarcoma distinction in routine tissue; leaves open prospective validation against current panels.
Does immunostaining with QBEnd/10 improve the diagnosis of Kaposi's sarcoma compared to UEA-1 and FVIIIRAg?
QBEnd/10 is a useful immunostain for distinguishing Kaposi's sarcoma from other spindle cell neoplasms in routinely processed tissue.
Sankey et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: